Markets
markets
Luke Kawa

Palo Alto Networks surges after posting better sales, earnings, and guidance than Wall Street anticipated

Palo Alto Networks is soaring after posting top- and bottom-line beats in the fourth quarter along with a bright outlook for its current fiscal year.

For the three months ended July 31, the seller of AI-enabled cybersecurity offerings generated revenues of $2.54 billion (ahead of estimates for $2.5 billion) with adjusted earnings per share of $0.95, 6 cents above Wall Street’s call.

Palo Alto Networks is basking in sell-side love after these results. Bank of America upgraded the shares to “buy,” while Truist hiked its price target to $220 from $205 and Rosenblatt upped its price target to $225 from $215.

Shares were up 6.6% in premarket trading.

The company provided Q1 and full-year 2026 guidance for sales that were modestly ahead of expectations, while the adjusted EPS outlook for both those periods more meaningfully exceeded what analysts had projected. This guidance does not include any impacts from its recently announced acquisition of CyberArk, which CEO Nikesh Arora touted as a way to offer “the most complete integrated security solution in the market” during a conference call with analysts.

“We continue to view this deal as a strategic home run by PANW as it continues its hunt to build an all-in-one solution for enterprises by adding a golden asset in CYBR who is the premier player in identity/privileged access management security,” wrote Wedbush Securities analyst Dan Ives, who included the stock in his “AI 30” list of favorites and has a $225 price target. “Cybersecurity is a clear 2nd/3rd derivative play in the AI Revolution leading to PANW ultimately emerging in the driver’s seat to gain market/mind share with last night’s strong quarter and outlook a key step forward for Nikesh & Co.”

More Markets

See all Markets
Max Knoblauch
10/3/25

Automakers spike on report that Trump administration is considering tariff relief

The Trump administration is considering significant tariff relief for many major automakers, according to reporting by Reuters.

“The signal to the car companies around the world is, look, you have final assembly in the US, we’re going to reward you,” Ohio Republican Senator Bernie Moreno told Reuters. “For Ford, for Toyota, for Honda, for Tesla, for GM, those are the almost in order the top five domestic content vehicle producers — they’ll be immune to tariffs.”

The senator told Reuters that President Trump could potentially extend the higher levels of tariff offsets announced by the Commerce Department in June.

According to the White House, Moreno’s comments should be considered “speculative,” but shares of vehicle makers including Ford, GM, Toyota, Honda, and Stellantis all rose after the report came out.

markets

Palantir disputes report of flaws in Army product

Palantir says security vulnerabilities with a prototype battlefield communications product highlighted in a September 5 Army memorandum have already been addressed, according to a Bloomberg report.

The company said any conclusions that the product was seriously flawed, drawn from reports in Reuters and an online publication known as Breaking Defense, were “out of date and inaccurate.”

Separately, Army officials also told Breaking Defense that deficiencies with the battlefield communication product were “mitigated immediately.”

Going into the last hour of trading, Palantir shares were on track for their worst day since August in the wake of the reports.

Separately, Army officials also told Breaking Defense that deficiencies with the battlefield communication product were “mitigated immediately.”

Going into the last hour of trading, Palantir shares were on track for their worst day since August in the wake of the reports.

markets

Novo says it will offer weight-loss pill via telehealth, Bloomberg reports

Hims & Hers slipped after Novo Nordisk’s US head, David Moore, told Bloomberg that the company plans to sell its upcoming weight-loss pill through its current telehealth partners.

The companys weight-loss pill recently reported encouraging results in a late-stage trial.

Novo currently has partnerships with Hims competitors like Ro and Weight Watchers. Hims had a deal with Novo earlier this year, which blew up epically in less than two months.

markets

Shopify soars after Rothschild Redburn hikes price target to $200

Shopify popped nearly 7% Friday afternoon after Rothschild Redburn reiterated its “buy” rating and raised its price target to $200 from $180, tying the highest on Wall Street and about 23% above current levels.

The firm pointed to Shopify’s new partnership with OpenAI’s ChatGPT as a key growth driver, saying it opens up a fresh sales channel that, for now, only Shopify and Etsy merchants can tap into. 

Analysts also highlighted that unlike the Magnificent 7 tech names, Shopify can fold AI revenue into its model without heavy capital spending, meaning those contributions could offer a quick boost to free cash flow. 

On that note, the firm also bumped its 2025 to 2027 earnings estimates by about 6% to 8%. Shopify shares have already more than doubled over the past year and are up roughly 50% year to date.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.